Literature DB >> 25953577

Implant site Nexplanon reaction?

Célia Pedroso1, Isabel Martins2, Fátima Palma2, Ana Isabel Machado2.   

Abstract

Nexplanon (Schering-Plough Limited/Merck Sharp & Dohme Limited (MSD)) is a long active reversible contraceptive method that provides effective contraception for 3 years. It consists of a single, flexible, rod-shaped implant, containing 68 mg etonogestrel. It is 4 cm long, consists of an ethylene vinyl acetate copolymer, a non-absorbable material, and also contains 15 mg of barium sulfate, which makes it visible by X-ray. We describe a case of a 39-year-old woman who experienced a local reaction to the barium sulfate in Nexplanon. She was given medical treatment, but only the removal of the implant resolved the symptoms. After removal there was gradual improvement and 72 h later the patient was asymptomatic. Allergic reaction to barium sulfate is extremely rare: until now, there have only been two cases associated with Nexplanon described in the literature. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25953577      PMCID: PMC4434278          DOI: 10.1136/bcr-2014-206256

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Adverse reaction to Nexplanon(R).

Authors:  Farah Chaudhry
Journal:  J Fam Plann Reprod Health Care       Date:  2013-07

2.  Anaphylaxis from the carboxymethylcellulose component of barium sulfate suspension.

Authors:  N Muroi; M Nishibori; T Fujii; M Yamagata; S Hosoi; N Nakaya; K Saeki; K Henmi
Journal:  N Engl J Med       Date:  1997-10-30       Impact factor: 91.245

3.  Allergy to nexplanon®.

Authors:  Martin J Sullivan
Journal:  J Fam Plann Reprod Health Care       Date:  2012-10
  3 in total
  2 in total

1.  Toxic epidermal necrolysis caused by etonogestrel implantation: A rare presentation.

Authors:  Minorvi Amin; Christopher D Liao; Roger L Simpson
Journal:  JAAD Case Rep       Date:  2022-06-13

Review 2.  Safety and Benefits of Contraceptives Implants: A Systematic Review.

Authors:  Morena Luigia Rocca; Anna Rita Palumbo; Federica Visconti; Costantino Di Carlo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.